Akzhan Konysbekova

Akzhan Konysbekova

Auto-generated profile, based on publicly available information

Akzhan Konysbekova

Research Institute of Cardiology and Internal Diseases

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 December 2024 in Наука и здравоохранение
Verified
Journal Article
Open access
AKA. Konysbekova
A. Konysbekova
MPM. Pashimov
M. Pashimov
AAAkmaral Abikulova
Akmaral Abikulova
LSLaura Seiduanova
Laura Seiduanova
OJO. Jumagaziyeva
O. Jumagaziyeva
AQA. Qumar
A. Qumar
Background. Cardiovascular diseases are the leading cause of death globally, accounting for 20.5 million deaths in 2021, according to the World Heart Report, and accounting for almost a third of all deaths in the world. Many cardiovascular disease events can be prevented by changes in behavioral risk factors, such as smoking and diet, as well as pharmacological interventions. One solution addressing this issue is disease management, which seeks to enhance healthcare by lowering the expenses of treating chronically ill individuals. Disease management programs effectively enhance care quality and adherence, ultimately reducing the misuse of resources. Aim. To analyze the results of implementing the Disease Management Program in Kazakhstan using chronic heart failure as an example over the years of implementation. Materials and methods. The necessary statistical data on implementing the Disease Management Program in Kazakhstan were collected using the chronic heart failure example. The research material was the Salidat Kayirbekova National Scientific Research Center for Health Development statistical collections and official reports of the Research Institute of Cardiology and Internal Diseases for 2018-2022. Results. The introduction of a disease management system for the management of chronic heart failure at the end of 2013-2022 contributed to a decrease in mortality from cardiovascular diseases by 4.3%, including from hypertension by 12%, coronary artery disease by 4%, and acute myocardial infarction by 4.8%. Quality of care within the healthcare system has advanced: patient coverage has expanded, and training sessions have been arranged for patients and healthcare professionals. Conclusions. These findings highlight the success of the implemented strategies and underscore the importance of continuous monitoring and evaluation to enhance healthcare outcomes further. Overall, the research underscores the positive trajectory of chronic disease management in Kazakhstan, paving the way for future improvements and sustained health benefits for the population. Введение. Сердечно-сосудистые заболевания являются основной причиной смертности во всем мире, на долю которых в 2021 году пришлось 20,5 миллиона смертей и составили почти треть всех смертей в мире (World Heart Report, 2023). Многие случаи сердечно-сосудистых заболеваний можно предотвратить путем изменения поведенческих рисков, в частности по курению и питанию, а также приверженности лечению. Одним из эффективных решений является управление заболеваниями, направленное на улучшение качества ухода за счет сокращения затрат, связанных с лечением хронических больных. Программы управления заболеваниями являются эффективным средством повышения качества ухода, соблюдения рекомендаций и, в итоге, сокращения нецелевого использования ресурсов. Цель проанализировать результаты реализации Программы управления заболеваниями в Казахстане на примере хронической сердечной недостаточности за годы реализации. Материалы и методы. Произведен сбор необходимых статистических данных по реализации Программы Управления Заболеваниями в Республике Казахстан на примере хронической сердечной недостаточности. Материалом исследования были: статистические сборники ННЦРЗ имени Салидат Каирбековой МЗ РК за 2013-2022 года и официальные отчеты КазНИИКиВБ за 2018-2023 года. Результаты. С 2013 по 2022 годы было достигнуто снижение смертности от сердечно-сосудистых заболеваний на 4,3%; включая снижение смертности от заболеваний, связанных с повышением артериального давления на 12%; ишемической болезни сердца на 4% и острого инфаркта миокарда на 4,8%. В рамках программы управления заболеваниями значительно улучшилось качество медицинской помощи: расширился охват пациентов, проведены обучающие курсы, как для пациентов, так и для работников службы здравоохранения. Заключение. Эти результаты подчеркивают успех реализованных стратегий и подчеркивают важность постоянного мониторинга и оценки для дальнейшего улучшения результатов здравоохранения. В целом, исследование подчеркивает положительную траекторию лечения хронических заболеваний в Казахстане, открывая путь к будущим улучшениям и устойчивым преимуществам для здоровья населения....

28 February 2026 in Journal of Health Development
Verified
Journal Article
Open access
PDF file
AGAigerim Galym
Aigerim Galym
ZSZhanar Sabyrdilda
Zhanar Sabyrdilda
AKAkzhan Konysbekova
Akzhan Konysbekova
AAAkmaral Abikulova
Akmaral Abikulova
LSLaura Seiduanova
Laura Seiduanova
КАКумар А.б.
Кумар А.б.
Objective: Pediatric demyelinating diseases of the central nervous system present with heterogeneous neurological impairments and varying clinical courses, often requiring long-term monitoring, immunological evaluation, and multidisciplinary care. The study aims to assess parental perceptions of their child’s health, symptom burden, comorbidities, exacerbation triggers, and access to rehabilitation among children with demyelinating diseases, and to examine associations between key clinical factors and functional outcomes. Methods: A cross-sectional survey was conducted among parents of 34 children aged 4–18 years hospitalized at Aksai University Clinic. A 39-item questionnaire was developed in accordance with international guidelines and pilot-tested for clarity. Statistical analysis included descriptive statistics, calculation of 95% confidence intervals (CI), and assessment of associations using odds ratios (OR) and Fisher’s exact test. Results: Neurological symptoms were highly prevalent, including coordination impairment (35.3%), visual disturbances (23.5%), speech disruption (17.6%), sensory deficits (14.7%), and pelvic dysfunction (5.9%). Most children (82.4%, 95% CI: 69.6–95.2) had a history of infections, and respiratory illnesses were common (53.0%). Infections were identified as the leading trigger of exacerbations (35.3%, 95% CI: 19.7–52.8), followed by non-adherence to medical recommendations (26.5%). Functional limitations affected 81% of children. Infection history was significantly associated with functional impairment (OR=3.1, 95% CI: 1.2–7.9; p=0.021), as was the presence of ≥2 neurological symptoms (OR=4.5, 95% CI: 1.1–18.2; p=0.047). Conclusion: Parental reports demonstrate pronounced multisystem involvement, elevated infection burden, and high rates of functional limitations in children with demyelinating diseases. These findings underscore the need for robust infection-prevention strategies, improved support for treatment adherence, standardized referral pathways, and expanded, continuous rehabilitation services for affected children.

30 June 2026 in Central Asian Journal of Medical Hypotheses and Ethics
Verified
Journal Article
Open access
RBRaushan Bayaliyeva
Raushan Bayaliyeva
EKErmagambet Kuatbaev
Ermagambet Kuatbaev
ARArgul Razbekova
Argul Razbekova
AKAinur Kumar
Ainur Kumar
BABakytzhan Akylbek
Bakytzhan Akylbek
DNDilara Nurbaeva
Dilara Nurbaeva
Background: Acute myocardial infarction (AMI) remains a major cause of mortality worldwide, with outcomes strongly influenced by healthcare system organization and timely access to reperfusion therapy. Evidence from Central Asia, including Kazakhstan, remains limited, particularly regarding real-world hospital-based outcomes. Objective: To assess clinical outcomes and temporal trends in the management of AMI in a tertiary cardiac center in Almaty, Kazakhstan. Methods: A retrospective observational cohort study was conducted at the City Cardiology Center in Almaty, including all adult patients with AMI admitted between 2023 and 2025. Data were obtained from hospital databases and institutional reports. Primary outcomes included in-hospital mortality, early (24-hour) mortality, and 30-day mortality. Secondary outcomes included procedural volumes and system performance indicators. Temporal trends were analyzed across study years. Results: In-hospital mortality remained stable (1.8% in 2023–2024 vs. 1.9% in 2025), as did AMI-specific mortality (6.0% in 2024 vs. 6.1% in 2025). However, significant improvements were observed in short-term outcomes. Early mortality decreased from 69 to 60 cases (–13.0%), while 30-day mortality declined from 176 to 163 cases (–7.4%). Post-discharge mortality also decreased from 57 to 48 cases (–15.8%). Procedural volumes showed mixed trends: PCI and stenting volumes decreased, while coronary angiography volumes remained stable or slightly increased. At the same time, system performance indicators improved substantially: the proportion of patients seeking care within 60 minutes increased from 55.2% to 89.0%, and the proportion of patients undergoing PCI within 60 minutes of arrival increased from 57.2% to 70.4%. Conclusion: Improvements in healthcare system performance, particularly reduced treatment delays and optimized care pathways, were associated with better short-term outcomes in AMI patients. These findings highlight the importance of system-level interventions and provide valuable evidence for strengthening cardiovascular care in Kazakhstan and other Central Asian countries.